Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
100.2 USD | -0.41% |
|
+1.72% | -0.60% |
Jun. 14 | Merit Medical is recalling unauthorized plastic syringes, US FDA says | RE |
Jun. 14 | Deutsche Bank Adjusts Cardinal Health Price Target to $115 From $110 | MT |
Evolution of the average Target Price on Cardinal Health, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cardinal Health, Inc.
Deutsche Bank Securities | |
Baird | |
JPMorgan Chase | |
Argus | |
Jefferies & Co. | |
Wells Fargo Securities | |
Leerink Partners | |
Evercore ISI | |
Morgan Stanley | |
UBS | |
Nephron Research | |
Morningstar | |
TD Cowen | |
Mizuho Securities | |
Citigroup | |
Barclays | |
Credit Suisse | |
Cowen | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- CAH Stock
- Consensus Cardinal Health, Inc.